Lindsay Fourman is an Endocrinology/Metabolic physician affiliated with Massachusetts General Hospital. OpenAlex indexes 56 publications with 924 citations (h-index 17); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingClinical trials
- Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV
Sponsor: Massachusetts General Hospital
- HIV Exposure in Utero and Metabolic Disease Risk in HIV-Negative Young Adults
Sponsor: Massachusetts General Hospital
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
4 companies with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
48.4%GLP-1 receptor agonist24.2%Trulicity68%Ozempic32%Part D<11 patientsCorticosteroid14.9%Prednisone100%Part D<11 patients+ 1 more class in this area
Hormonal (systemic)
21.4%l-Thyroxine12.9%Levothyroxine Sodium66%Synthroid34%Part D<11 patientsGrowth Hormone Releasing Factor Analog8.5%Egrifta Sv100%Part D<11 patientsGenitourinary & hormones
21%Androgen21%Testosterone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2020–2025 per NIH RePORTER. The latest:
- Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV (TRIUMPH)
Massachusetts General Hospital
FY2025$665,909R01AG087809 - Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV (TRIUMPH)
Massachusetts General Hospital
FY2024$697,594R01AG087809 - In Utero HIV Exposure and Metabolic Disease Risk in HIV-Uninfected Young Adults
Massachusetts General Hospital
FY2024$136,577K23HD100266
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Muscle movement and metabolism: exercise and skeletal muscle as mediators of health—a report from the 26th Annual Harvard Nutrition Obesity Symposium, 2025
American Journal of Clinical Nutrition
2026 - Metabolic dysfunction-associated steatotic liver disease in people with HIV
Current Opinion in HIV and AIDS
2025 - MON-696 Obesity and Metabolic Comorbidities in Young Adults with Perinatal HIV Exposure Without Infection
Journal of the Endocrine Society
2025
Similar KOLs
Other experts from the same institution or the same specialty.
James Januzzi, MD
Massachusetts General Hospital
Maurizio Fava, MD
Massachusetts General Hospital
Steven Greenberg, MD
Massachusetts General Hospital
David Scadden, MD
Massachusetts General Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”